Shopping Cart 0
Cart Subtotal
USD 0

Luminex Corp (LMNX) - Medical Equipment - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: Yes
Copy Option: No
Deliverable Format : PDF Via Email

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Deliverable Format : Excel, PDF Via Email

Corporate User License
USD 750
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Details

Summary

Luminex Corp (Luminex) is a medical devices company which develops, manufactures and markets proprietary biological testing technologies. The company offers wide range of products including instruments, assays, reagents and accessories, software and replacement parts. Its proprietary technologies consist of xMAP, xTAG and MultiCode. Luminex offers its products to various markets such as clinical diagnostics; pharmaceutical drug discovery; biomedical research including personalized medicine, genomic and proteomic research, biodefense research and food safety. The company sells its products through direct sales channel and strategic distribution partners in North America, Europe and Asia-Pacific. Luminex is headquartered in Texas, the US.

Luminex Corp (LMNX)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Luminex Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Luminex Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Luminex Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Luminex Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 8

Luminex Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Luminex Corp, Medical Equipment, Deal Details 10

Partnerships 10

Natural Molecular Testing Enters Into Licensing Agreement With Luminex 10

Merck Enters Into Licensing Agreement With Luminex To Develop Companion Diagnostic Device 11

Genetic Analysis Enters into Agreement with Luminex 12

Luminex Enters into Distribution Agreement with Bio-Techne 13

Affymetrix Enters into Distribution Agreement with Luminex 14

TheraDiag Enters Into Distribution Agreement With Luminex For xTAG RVP And xTAG GPP 15

Luminex Extends Distribution Agreement With EMD Millipore 16

Bio-Rad Labs Extends Distribution Agreement With Luminex For MAGPIX 17

Asset Transactions 18

Luminex Plans To Sell Newborn Screening Business 18

Acquisition 19

Luminex Acquires Nanosphere in Tender Offer 19

Luminex Completes Acquisition Of GenturaDx, Molecular Diagnostics Company, For Upto USD60 Million 21

Luminex Corp-Key Competitors 23

Luminex Corp-Key Employees 24

Luminex Corp-Locations And Subsidiaries 25

Head Office 25

Other Locations & Subsidiaries 25

Recent Developments 27

Financial Announcements 27

Aug 06, 2018: Luminex reports second quarter 2018 financial results 27

May 07, 2018: Luminex Announces First Quarter 2018 Financial Results 28

Feb 12, 2018: Luminex Reports Fourth Quarter and Full-Year 2017 Financial Results 29

Oct 30, 2017: Luminex Reports Third Quarter 2017 Financial Results 30

Aug 07, 2017: Luminex Reports Second Quarter 2017 Financial Results 31

May 01, 2017: Luminex Reports Record First Quarter 2017 Financial Results; Raises 2017 Financial Guidance 32

Feb 06, 2017: Luminex Reports Fourth Quarter And Full Year 2016 Results 33

Jan 09, 2017: Luminex Announces Preliminary Revenue for Fourth Quarter 2016 and Issues 2017 Revenue Guidance 34

Product News 35

Oct 26, 2017: Vanderbilt Clinical Labs Choose VERIGENE Blood Culture Tests 35

Other Significant Developments 36

Aug 29, 2017: Luminex and Sutter Health Collaborate to Improve Patient Care 36

Appendix 37

Methodology 37

About GlobalData 37

Contact Us 37

Disclaimer 37


List Of Figure

List of Figures

Luminex Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 2

Luminex Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 2

Luminex Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 2

Luminex Corp, Medical Equipment, Deals By Market, 2012 to YTD 2018 2

Luminex Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Luminex Corp, Medical Equipment, Deals by Type, 2012 to YTD 2018 6

Luminex Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Luminex Corp, Medical Equipment, Deals by Market, 2012 to YTD 2018 8


List Of Table

List of Tables

Luminex Corp, Medical Equipment, Key Facts, 2017 2

Luminex Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 2

Luminex Corp, Medical Equipment, Deals By Year, 2012 to YTD 2018 5

Luminex Corp, Medical Equipment Deals By Type, 2012 to YTD 2018 6

Luminex Corp, Medical Equipment, Deals By Region, 2012 to YTD 2018 7

Luminex Corp, Deals By Market, 2012 to YTD 2018 8

Luminex Corp, Medical Equipment, Deals Summary, 2012 to YTD 2018 9

Natural Molecular Testing Enters Into Licensing Agreement With Luminex 10

Merck Enters Into Licensing Agreement With Luminex To Develop Companion Diagnostic Device 11

Genetic Analysis Enters into Agreement with Luminex 12

Luminex Enters into Distribution Agreement with Bio-Techne 13

Affymetrix Enters into Distribution Agreement with Luminex 14

TheraDiag Enters Into Distribution Agreement With Luminex For xTAG RVP And xTAG GPP 15

Luminex Extends Distribution Agreement With EMD Millipore 16

Bio-Rad Labs Extends Distribution Agreement With Luminex For MAGPIX 17

Luminex Plans To Sell Newborn Screening Business 18

Luminex Acquires Nanosphere in Tender Offer 19

Luminex Completes Acquisition Of GenturaDx, Molecular Diagnostics Company, For Upto USD60 Million 21

Luminex Corp, Key Competitors 23

Luminex Corp, Key Employees 24

Luminex Corp, Other Locations 25

Luminex Corp, Subsidiaries 25

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

Products and Companies

Products

Luminex Corp, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.